TY  - CHAP
M1  - Book, Section
TI  - Transitions in Global Disease Burden
A1  - Temesgen, Awoke Misganaw
A1  - Murray, Christopher J. L.
A2  - Boulton, Matthew L.
A2  - Wallace, Robert B.
PY  - 2022
T2  - Maxcy-Rosenau-Last Public Health & Preventive Medicine, 16e
AB  - A  transition  in  disease  burden,  the  general  notion  of  a  shift  from  communicable  to  noncommunicable  causes  of  disease  and  injury,  remains  a  powerful  framework  for  global  and  regional  health  policy  debates.1  In  1971,  Omran  outlined  the  concept  of  the  epidemiological  transition  to  describe  the  changing  pattern  of  causes  of  death  that  results  from  sociodemographic  development.2  The  epidemiological  transition  is  an  extension  of  the  conception  of  the  demographic  transition.  In  the  demographic  transition,  a  characteristic  evolution  occurs  in  populations  over  time  toward  reduced  fertility  rates,  reduced  mortality  rates,  and  an  older-age  distribution  of  the  population.  The  widely  used  concept  of  the  epidemiological  transition  adds  the  idea  that,  in  addition  to  these  changes,  a  characteristic  change  occurs  in  the  contributing  causes  of  death.1  The  epidemiological  transition  has  been  broadened  to  encompass  a  more  general  health  transition,  including  both  morbidity  and  mortality.  The  developments  of  modern  healthcare  and  medicine  drastically  reduce  infant  mortality  rates  and  extend  average  life  expectancy.  These  factors,  coupled  with  subsequent  declines  in  fertility  rates,  have  catalyzed  a  transition  to  noncommunicable  diseases  (NCDs)  as  increasingly  important  causes  of  health  loss.  The  notion  of  the  epidemiological  transition  has  also  been  expanded  to  recognize  a  transition  phase  that  may  lead  to  a  double  burden  of  disease,  the  growing  threat  of  NCDs  as  causes  of  health  loss  while  infectious  diseases  remain  highly  prevalent.  Too  often,  the  health  system  may  continue  to  rely  heavily  on  the  conventional  infectious  disease  paradigm  and  be  unresponsive  to  this  emerging  epidemiological  shift.3  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/24
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1182682481
ER  -